[go: up one dir, main page]

Yang, 2021 - Google Patents

Central Amygdala-Associated Behavioural Phenotypes in a Gain-of-Function Voltage-Gated Sodium Channel NaV1. 5 Mouse Model

Yang, 2021

View PDF
Document ID
15665405220226700790
Author
Yang C
Publication year

External Links

Snippet

Abstract Tetrodotoxin-resistant (TTXr) voltage-gated sodium channels (VGSCs) have different electrophysiological properties than TTX-sensitive VGSCs. Na V 1.5 is a TTXr VGSC mainly responsible for mediating cardiac action potentials, however it has also been …
Continue reading at utoronto.scholaris.ca (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Similar Documents

Publication Publication Date Title
Amador et al. Modelling and treating GRIN2A developmental and epileptic encephalopathy in mice
Wang et al. Altered mGluR5-Homer scaffolds and corticostriatal connectivity in a Shank3 complete knockout model of autism
Barrett et al. The oxytocin system promotes resilience to the effects of neonatal isolation on adult social attachment in female prairie voles
Shorvon et al. Oxford textbook of epilepsy and epileptic seizures
Armstrong et al. Calcium channel agonists protect against neuromuscular dysfunction in a genetic model of TDP-43 mutation in ALS
Vyas et al. Influence of maternal zinc supplementation on the development of autism-associated behavioural and synaptic deficits in offspring Shank3-knockout mice
Zhu et al. Nucleus accumbens D1/D2 circuits control opioid withdrawal symptoms in mice
Cooper et al. Endogenous µ‐opioid receptor activity in the lateral and capsular subdivisions of the right central nucleus of the amygdala prevents chronic postoperative pain
EP2575853A1 (en) Methods and pharmaceutical composition for the treatment of a feeding disorder with early-onset in a patient
Vermudez et al. Profiling beneficial and potential adverse effects of MeCP2 overexpression in a hypomorphic Rett syndrome mouse model
D’Oliveira da Silva et al. Targeting Nociceptin/Orphanin FQ receptor to rescue cognitive symptoms in a mouse neuroendocrine model of chronic stress
Ahmed et al. Pro-inflammatory cytokine GM-CSF improves learning/memory and brain pathology in Dp16 down syndrome mice and improves learning/memory in wild-type mice
Yang Central Amygdala-Associated Behavioural Phenotypes in a Gain-of-Function Voltage-Gated Sodium Channel NaV1. 5 Mouse Model
Brun et al. Ultrasound-induced seizures in a mouse model of KCNQ2-NEO-DEE
WO2005110018A2 (en) Therapies which act on neuropeptide s receptors
WO2013013338A1 (en) Use of substances targeting gc-c signaling pathway in diagnosis and treatment for midbrain dopamine neurons diseases
김하윤 TRP channel mediated peripheral nociceptive mechanism and central analgesic neural circuit
Flais Regulatory Proteins modulating Signalling Pathways in Schizophrenia-associated Mouse Models
Kawahara et al. Ghrelin restores D1 receptor-mediated dopamine neurotransmission and enhances attentive behaviour in Mecp2 KO mice
Anne Delineating the Roles of Perturbed Neuronal Networks and Glial Cells in a Mouse Model of SCN8A Developmental and Epileptic Encephalopathy
Pedersen Constraint of Motivation and Value by Limbic Opioidergic Systems
Flores The Role of KCC3 in Neuronal Homeostasis
Stein Kindling Dravet Syndrome Symptoms from the Hippocampus
Fisher Role of HCN Channels in Behavioral Responses to Psychosocial Stress
Son et al. P. 1282, 6-Dimethoxy-1, 4-benzoquinone increases skeletal muscle mass through Akt/mTOR signaling pathway